Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
01/12/2011 | CN101945650A Combination comprising a cannabinoid receptor binding compound and an opioid |
01/12/2011 | CN101940789A Application of glucocorticoid to preparing medicament for treating tardive hemorrhagic cystitis |
01/12/2011 | CN101940788A Application of antidepressant in treatment of stress gastric ulcer |
01/12/2011 | CN101940551A Self-assembly nano-particles of sulfhydrylation chitosan quaternary ammonium salt and preparation method and application thereof |
01/12/2011 | CN101612401B Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
01/12/2011 | CN101327182B Preparation of nano crystal fibre felt of water-insoluble medicament |
01/11/2011 | US7868042 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; for improving renal function; nitric oxide synthase modulators; hypotensive agents |
01/11/2011 | US7868040 Anti-cancer combinations |
01/11/2011 | US7868039 Anti-cancer combinations |
01/11/2011 | US7867986 Enhanced drug delivery in transdermal systems |
01/11/2011 | US7867764 replication-defective recombinant adenovirus comprising a heterologous nucleic acid sequence encoding an antigenic determinant of Plasmodium falciparum that comprises an immunogenic peptide of the circumsporozoite protein; viral vectors |
01/11/2011 | US7867518 Controlled release compositions for interferon based on PEGT/PBT block copolymers and method for preparation thereof |
01/11/2011 | US7867509 Fast dissolving orally consumable films |
01/11/2011 | US7867508 administering a decongestant(oxymetazoline hydrochloride), a corticosteroid (triamcinolone acetate) and anticholinergic agent ipratropium bromide for nonaddictive treatment of upper respiratory conditions in man and animals, e.g., allergic, non-allergic and mixed rhinitis in man or pharyngitis in horses |
01/11/2011 | US7867498 comprise at least five CD4+ T cell epitopes, for conjugation to capsular polysaccharides; for use in treatment and prevention of plasmodial infection; genetic vaccines; for immunization |
01/11/2011 | US7867481 Method of treating anemia by administering IL-1ra |
01/11/2011 | CA2472149C New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments |
01/11/2011 | CA2460696C Use of substituted aminomethyl chromans for the treatment of extrapyramidal movement disorders |
01/11/2011 | CA2453996C Injectable pharmaceutical formulations |
01/11/2011 | CA2436891C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
01/11/2011 | CA2429781C Linkable sialyl lewis x analogs |
01/11/2011 | CA2400486C Aniline-derived ligands for the thyroid receptor |
01/11/2011 | CA2378883C Methods of reducing microbial resistance to drugs |
01/11/2011 | CA2374039C Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
01/11/2011 | CA2349406C Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
01/06/2011 | WO2011002606A1 Methods of identifying a patient population eligible for treatment with nitric oxide via inhalation |
01/06/2011 | WO2011002026A1 Amyloid fibril formation inhibitor and use thereof |
01/06/2011 | WO2011001440A1 Pharmaceutical compositions of valsartan |
01/06/2011 | WO2011000930A1 L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin |
01/06/2011 | WO2010081825A3 Pirenzepine as an agent in cancer treatment |
01/06/2011 | WO2010056985A8 Treatment of proteinopathies using a farnesyl transferase inhibitor |
01/06/2011 | US20110003764 Methods for Treatment of HIV or Malaria Using Combinations of Chloroquine and Protease Inhibitors |
01/06/2011 | US20110003746 Protein variants |
01/06/2011 | US20110003388 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
01/06/2011 | US20110002983 Compound |
01/06/2011 | US20110002957 Hapten-carrier conjugates for treating and preventing nicotine addiction |
01/06/2011 | US20110002946 Immunostimulatory Combinations |
01/06/2011 | US20110002910 Therapeutic agents comprising pro-apoptotic proteins |
01/06/2011 | US20110002887 Combinations of antibodies selective for dr5 and other therapeutic agents |
01/06/2011 | CA2766706A1 L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin |
01/06/2011 | CA2753290A1 Topical skin treatment kits |
01/05/2011 | EP2270131A1 Feline probiotic lactobacilli |
01/05/2011 | EP2270107A1 Compounds for Dual Photodiagnosis and Therapy |
01/05/2011 | EP2270052A2 Antibodies to OPGL |
01/05/2011 | EP2269694A2 Antituberculous composition comprising oxazole compounds |
01/05/2011 | EP2269656A2 Selected antibodies binding to anionic phospholipids and aminophospholipids and their use in treatment |
01/05/2011 | EP2269654A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
01/05/2011 | EP2269649A2 Compositions containing a capillary active system with application-related differentiability, and the use thereof |
01/05/2011 | EP2269648A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
01/05/2011 | EP2269647A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
01/05/2011 | EP2269646A1 Prophylactic or therapeutic agent for diabetes or obesity |
01/05/2011 | EP2269632A2 Immunostimulatory compositions and methods of stimulating an immune response |
01/05/2011 | EP2269628A2 Pancreas-specific proteins |
01/05/2011 | EP2269620A1 Therapeutic uses of dunaliella powder |
01/05/2011 | EP2269606A2 Transdermal analgesic systems having reduced abuse potential |
01/05/2011 | EP2269604A1 Treatment of solid tumours with rapamycin derivatives |
01/05/2011 | EP2269603A1 Treatment of solid tumours with rapamycin derivatives |
01/05/2011 | EP2269602A1 Antibiotic compositions for treatment of the eye, ear and nose |
01/05/2011 | EP2269598A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
01/05/2011 | EP2269596A2 Use of adenosine A2a receptor antagonists for the treatment of extrapyramidal syndrome and other movement disorders |
01/05/2011 | EP2269590A2 Ion binding polymers and uses thereof |
01/05/2011 | EP2269589A2 Ion binding polymers and uses thereof |
01/05/2011 | EP2269579A2 Tamper-resistant products for opioid delivery |
01/05/2011 | EP2268312A2 Treatment of intervertebral disc degeneration |
01/05/2011 | EP2268299A1 Compositions and method for reducing scar formation in wound healing |
01/05/2011 | EP2268279A1 Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl¨-3-oxoisoindoline-4-yl}carboxamide |
01/05/2011 | EP2029139B1 Use of a p38 kinase inhibitor for treating psychiatric disorders |
01/05/2011 | EP2016950B1 Pharmaceutical composition comprising an exendin-4 peptide |
01/05/2011 | EP1908467B1 Agent for treating herpesvirus-derived pain |
01/05/2011 | EP1771551B1 Novel cell populations and uses thereof |
01/05/2011 | EP1750862B1 Pharmaceutical composition containing irbesartan |
01/05/2011 | EP1750667B1 Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections |
01/05/2011 | EP1619498B1 Method of screening remedy for heart disease and medicinal composition for treating heart disease |
01/05/2011 | EP1558256B1 Pyrroloquinoline quinone and a beta blocker for the treatment of ischemia or reperfusion injury |
01/05/2011 | EP1546182B1 Compositions and methods for the diagnosis and treatment of tumor |
01/05/2011 | EP1493034B1 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
01/05/2011 | EP1465637B1 25-hydroxy vitamin d3 compositions |
01/05/2011 | EP1463806B1 Novel cyclooxygenase variants and methods of use |
01/05/2011 | EP1437043B1 Rat model with overexpression of regucalcin |
01/05/2011 | EP1365778B1 Treating pulmonary disorders with gaseous agent causing repletion of gsno |
01/05/2011 | EP1294769B1 Antibodies that immunospecifically bind to blys |
01/05/2011 | EP1128814B1 Aerosols comprising nanoparticle drugs |
01/05/2011 | CN101939329A Amino acid pairing-based self assembling peptides and methods |
01/05/2011 | CN101939026A Antibacterial combination therapy |
01/05/2011 | CN101939025A Therapeutic agent for pruritus |
01/05/2011 | CN101939022A Methods for treating obesity and obesity related diseases and disorders |
01/05/2011 | CN101939017A Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament |
01/05/2011 | CN101939001A Combination comprising paclitaxel for treating ovarian cancer |
01/05/2011 | CN101935673A Method for promoting liver regeneration by adjusting GAT-1 expression |
01/05/2011 | CN101934078A Pharmaceutical composition comprising drospirenone and estrogen, and application thereof |
01/05/2011 | CN101934070A Veterinary antibacterial drug composition containing lysozyme and oligosaccharide and application thereof |
01/04/2011 | US7863322 Anti-cancer combinations |
01/04/2011 | US7863321 Anti-cancer combinations |
01/04/2011 | US7863320 Synergistic combinations of the compound 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and a compound selected from carboplatin, gemcitabine, cisplatin, 5-fluorouracil, cyclophosphamide, etoposide, vincristine, doxorubicin and irinotecan |
01/04/2011 | US7863287 Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
01/04/2011 | US7863261 androgen receptor modulator; analogs of androst-5-ene-3 beta ,17 beta -diol ("AED") or 1,3,5(10)-estratriene-17 alpha -ethynyl-3 beta ,17 beta -diol ("EED") |
01/04/2011 | US7863254 Administering cytosine-containing or cytidine-containing compound, creatine- containing compound, adenosine-containing, or adenosine- elevating compound; e.g., CDP, CDP-choline, S-adenosylmethionine) or triacetyluridine |
01/04/2011 | US7863241 Lung surfactant polypeptide, and at least one inhibitor of a mediator of tissue destruction; for example protease inhibitors; treating inflammatory lung conditions such as asthma, chronic obstructive pulmonary disease |
01/04/2011 | US7862831 Priming extracellular matrix by treating with a priming agent; adding to the primed extracellular matrix a solution of a polymerizable agent; reacting the primed extracellular matrix and polymerizable agent to create a hydrogel covalently bound to the extracellular matrix |
01/04/2011 | US7862829 Enhance immunology response ti immunogen; alpha virus adjuvant or Venezuelan Equine Encephalatis virua adjuvants |